Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
2021 | PD-L1 expression and outcome in patients with metastatic non-small cell lung cancer and EGFR mutations receiving EGFR-TKI as frontline treatment | Chang C.-Y.; Lai Y.-C.; Wei Y.-F.; CHUNG-YU CHEN ; Chang S.-C. | OncoTargets and Therapy | 6 | 6 | |
2022 | Plasma Concentrations of sTREM-1 as Markers for Systemic Adverse Reactions in Subjects Treated With Weekly Rifapentine and Isoniazid for Latent Tuberculosis Infection | Wang T.-Y.; Feng J.-Y.; CHIN-CHUNG SHU ; Lee S.S.-J.; CHUNG-YU CHEN ; Wei Y.-F.; Lin C.-B.; Huang W.-C.; Su W.-J.; Lin S.-M. | Frontiers in Microbiology | 3 | 2 | |
2022 | Prevalence of Latent Tuberculous Infection in Patients with Nontuberculous Mycobacterial Lung Disease and Colonization: A Prospective Study in an Intermediate Tuberculosis Burden Country | Lee H.-S.; Wei Y.-F.; Tsai Y.-J.; Wang P.-H.; CHUNG-YU CHEN ; Pan S.-W.; CHIN-CHUNG SHU | Open Forum Infectious Diseases | 1 | 1 | |
2007 | Pulmonary infarction from central venous air embolism mimicking round pneumonia | SHIH-CHI KU ; Wei Y.-F.; Lin, Lung-Chun | Thorax | 3 | 3 | |
2019 | Ramucirumab plus erlotinib in patients with untreated, EGFR-mutated, advanced non-small-cell lung cancer (RELAY): a randomised, double-blind, placebo-controlled, phase 3 trial | Nakagawa K.; Garon E.B.; Seto T.; Nishio M.; Ponce Aix S.; Paz-Ares L.; Chiu C.-H.; Park K.; Novello S.; Nadal E.; Imamura F.; Yoh K.; JIN-YUAN SHIH ; Au K.H.; Moro-Sibilot D.; Enatsu S.; Zimmermann A.; Frimodt-Moller B.; Visseren-Grul C.; Reck M.; Chu Q.; Cortot A.; Pujol J.-L.; Fabre E.; Lamour C.; Bischoff H.; Kollmeier J.; Kimmich M.; Engel-Riedel W.; Hammerschmidt S.; Schütte W.; Syrigos K.; Ho J.C.M.; Au K.-H.; Ardizzoni A.; Pasello G.; Gregorc V.; Del Conte A.; Galetta D.; Takahashi T.; Kumagai T.; Hotta K.; Goto Y.; Hosomi Y.; Sakai H.; Takiguchi Y.; Kim Y.H.; Kurata T.; Yamaguchi H.; Daga H.; Okamoto I.; Satouchi M.; Ikeda S.; Kasahara K.; Atagi S.; Azuma K.; Aoe K.; Horio Y.; Yamamoto N.; Tanaka H.; Watanabe S.; Nogami N.; Ozaki T.; Koyama R.; Hirashima T.; Kaneda H.; Tomii K.; Fujita Y.; Seike M.; Nishimura N.; Kato T.; Ichiki M.; Saka H.; Hirano K.; Nakahara Y.; Sugawara S.; Kim S.-W.; Min Y.J.; Lee H.W.; Kang J.-H.; An H.J.; Lee K.H.; Kim J.-S.; Lee G.-W.; Lee S.Y.; Alexandru A.; Udrea A.A.; Juan-Vidal Ó.; Nadal-Alforja E.; Gil-Bazo I.; Ponce-Aix S.; Rubio-Viqueira B.; Alonso Garcia M.; Felip Font E.; Fuentes Pradera J.; Coves Sarto J.; Lin M.-C.; Su W.-C.; Hsia T.-C.; Chang G.-C.; Wei Y.-F.; Su J.; Cicin I.; Goksel T.; Harputluoglu H.; Ozyilkan O.; Henning I.; Popat S.; Hatcher O.; Mileham K.; Acoba J.; Garon E.; Jung G.; Raj M.; Martin W.; Dakhil S. | The Lancet Oncology | 397 | 341 | |
2021 | Real-world effectiveness of second-line Afatinib versus chemotherapy for the treatment of advanced lung squamous cell carcinoma in immunotherapy-naïve patients | Chen Y.-Y.; Chang S.-C.; Chang C.-Y.; Chang C.-F.; Lai Y.-C.; Wei Y.-F.; CHUNG-YU CHEN | BMC Cancer | 0 | 0 | |
2022 | RELAY, Ramucirumab Plus Erlotinib Versus Placebo Plus Erlotinib in Patients with Untreated, Epidermal Growth Factor Receptor Mutation-Positive, Metastatic Non-Small-Cell Lung Cancer: Safety Profile and Manageability | Nadal E.; Horinouchi H.; JIN-YUAN SHIH ; Nakagawa K.; Reck M.; Garon E.B.; Wei Y.-F.; Kollmeier J.; Frimodt-Moller B.; Barrett E.; Lipkovich O.; Visseren-Grul C.; Novello S. | Drug Safety | 6 | 5 | |
2019 | Risk of sepsis among patients with COPD treated with fixed combinations of inhaled corticosteroids and long-acting Beta2 agonists | Wang C.-Y.; Lin Y.S.; Wang Y.-H.; Lai C.-C.; HAO-CHIEN WANG ; Chen L.; CHONG-JEN YU ; Perng D.-W.; Cheng S.-L.; Hsu J.-Y.; Hsu W.-H.; Tsai Y.-H.; Hsiue T.-R.; Lin M.-C.; Lin H.-I.; Wang C.-Y.; YEUN-CHUNG CHANG ; Yang U.-C.; Chen C.-M.; Lin C.-S.; Chen L.; Wei Y.-F.; Chong I.-W.; CHUNG-YU CHEN ; On the behalf of Taiwan Clinical Trial Consortium for Respiratory Diseases (TCORE) | Aging | 7 | 6 | |
2016 | Risk of tuberculosis among patients on dialysis | CHIN-CHUNG SHU ; CHIA-LIN HSU ; Wei Y.-F.; CHIH-YUAN LEE ; Liou H.-H.; VIN-CENT WU ; FENG-JUNG YANG ; HSIEN-HO LIN ; JANN-YUAN WANG ; JIN-SHING CHEN ; CHONG-JEN YU ; LI-NA LEE | Medicine (United States) | 17 | 14 | |
2020 | Safety and treatment completion of latent tuberculosis infection treatment in the elderly population—A prospective observational study in Taiwan | Feng J.-Y.; Huang W.-C.; Lin S.-M.; Wang T.-Y.; Lee S.S.-J.; CHIN-CHUNG SHU ; Pan S.-W.; CHUNG-YU CHEN ; Lin C.-B.; Wei Y.-F.; Tung C.-L.; Li C.-P.; Su W.-J. | International Journal of Infectious Diseases | 14 | 13 | |
2016 | Scabies increased the risk and severity of COPD: A nationwide population-based study | Chen J.-Y.; Liu J.-M.; Chang F.-W.; Chang H.; Cheng K.-C. ; Yeh C.-L.; Wei Y.-F.; KUAN-CHEN CHENG | International Journal of COPD | 10 | 10 | |
2010 | Serum soluble triggering receptor expressed on myeloid cells-1 in acute respiratory distress syndrome: A prospective observational cohort study | Lin M.-T.; Wei Y.-F.; SHIH-CHI KU ; Lin C.-A.; CHAO-CHI HO ; CHONG-JEN YU | Journal of the Formosan Medical Association | 7 | 7 | |
2006 | Successful treatment of intractable hemothorax with recombinant factor VIIa in a nonhemophilic patient | Wei Y.-F.; CHAO-CHI HO ; Lin M.-T.; ANG YUAN ; CHONG-JEN YU | Journal of the Formosan Medical Association | 1 | 1 | |
2011 | Surgically induced weight loss, including reduction in waist circumference, is associated with improved pulmonary function in obese patients | Wei Y.-F.; Tseng W.-K.; Huang C.-K.; Tai C.-M.; Hsuan C.-F.; HUEY-DONG WU | Surgery for Obesity and Related Diseases | 26 | 22 | |
2017 | Taiwanese Dermatological Association consensus for the prevention and management of epidermal growth factor receptor tyrosine kinase inhibitor-related skin toxicities | CHIA-YU CHU ; KUAN-YU CHEN ; Wen-Cheng Chang J.; Wei Y.-F.; Lee C.-H.; Wang W.-M. | Journal of the Formosan Medical Association | 21 | 16 | |
2018 | Treatment effectiveness and tolerability of afatinib at different doses in patients with EGFR-mutated lung adenocarcinoma: How low can we go? | Lim C.-K.; Wei Y.-F.; Tsai M.-S.; KUAN-YU CHEN ; JIN-YUAN SHIH ; CHONG-JEN YU | European Journal of Cancer | 18 | 14 | |
2015 | Wheezing, a significant clinical phenotype of COPD: Experience from the Taiwan Obstructive Lung Disease Study | Huang W.-C.; Tsai Y.-H.; Wei Y.-F.; PING-HUNG KUO ; Tao C.-W.; Cheng S.-L.; Lee C.-H.; Wu Y.-K.; Chen N.-H.; Hsu W.-H.; Hsu J.-Y.; Wang C.-C.; Lin M.-S. | International Journal of COPD | 16 | 12 | |